Camber (Camber)
Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 31722-669
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 31722-669). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Ranolazine-1000mg (Ranolazine 1000mg)
This is a medication information for Ranolazine Extended-Release Tablets. Each tablet contains 1000 mg of ranolazine and should be swallowed whole without crushing, breaking, or chewing. The medication should be stored at 20° to 25°C. The package insert should be consulted for dosage and administration information. The medication is manufactured by Camber Pharmaceuticals for Hetero Labs Limited in Hyderabad, India. Contact information for the manufacturer is provided.*
Ranolazine-500mg (Ranolazine 500mg)
Camber is an extended-release tablet of Ranolazine, a medication used to treat chest pain. Each tablet contains 500mg of Ranolazine and is not supposed to be crushed, broken, or chewed before swallowing. The tablets should be stored at room temperature between 20°C to 25°C. Dosage and administration instructions are provided in the package insert. Patients can refer to the medication guides available on the manufacturer's website. Camber is manufactured for Camber Pharmaceuticals, Inc. in Piscataway, New Jersey, USA. Batch information including manufacturing and licensing details is provided on the packaging.*
Ranolazine-structure (Ranolazine Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
